StonvexLoading…
StonvexStonvexStonvexCore line items from CUE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $5.69M | $27.47M | $5.52M | $3.37M |
Operating Income | $-5.35M | $-26.55M | $-28.53M | $-20.93M |
Net Income | $-5.18M | $-26.60M | $-28.19M | $-20.74M |
EPS (Diluted) | $-1.08 | $-0.28 | $-0.31 | $-0.24 |
Total Assets | $30.88M | $42.21M | $31.64M | $40.71M |
Total Liabilities | $9.27M | $15.78M | $18.40M | $22.55M |
Cash & Equivalents | $16.38M | $27.14M | $11.70M | $27.49M |
Free Cash Flow OCF − CapEx | $-11.06M | $-21.86M | $-20.79M | $-11.76M |
Shares Outstanding | 3.26M | 3.22M | 77.78M | 76.45M |